Does Synagis have any drug interactions?
No formal drug-drug interaction studies were conducted. In the IMpact- RSV trial, Synagis was associated with any increase in adverse reactions among children who received routine childhood vaccines, influenza vaccine, bronchodilators, or steroids. Q: Who should receive Synagis? Synagis is indicated for the prevention of serious lower respiratory tract disease caused by RSV. Candidates for prophyaxis with Synagis include premature infants (32 weeks gestation) without bronchopulmory dysplasia (BPD). Other candidates include infants with BPD requiring medical management in the prior six months. Other infants (35 weeks gestation) at risk for RSV may be considered on a case-by-case basis, especially if any of the following risk factors are present multiple birth, crowded household (> 4 people, or siblings) child will be going to day care, if smokers are present in the household, especially the mother. Some infants may benefit from prophylaxis for two RSV seasons. Q: Can Synagis be given wi
